MAVERICK™ Total Disc Replacement- Pivotal Study

Completed · Phase 3

Conditions studied: Spinal Diseases

In brief

The purpose of this clinical trial is to assess the safety and effectiveness of the MAVERICK™ Total Disc Replacement as a method of treating patients with lumbar degenerative disc disease at one level from L4-S1, with overall success being the primary endpoint of the clinical trial. The primary objective is to show non-inferiority of the investigational device to the control treatment. If non-inferiority is established, superiority will be examined.

Key facts

Study ID
NCT00635843
Run by
Medtronic Spinal and Biologics
People needed
577
Starts
2003-04-01
Expected to finish
2010-11-01
Last updated by the study team
2013-08-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.